NANECH
NanoEcho AB (publ) engages in developing diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden.
NANECH (NANECH) - Total Assets
Latest total assets as of December 2025: Skr18.42 Million SEK
Based on the latest financial reports, NANECH (NANECH) holds total assets worth Skr18.42 Million SEK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NANECH - Total Assets Trend (2022–2025)
This chart illustrates how NANECH’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NANECH - Asset Composition Analysis
Current Asset Composition (December 2025)
NANECH's total assets of Skr18.42 Million consist of 17.9% current assets and 82.1% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 11.6% |
| Accounts Receivable | Skr0.00 | 0.0% |
| Inventory | Skr0.00 | 0.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr14.88 Million | 80.8% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how NANECH's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NANECH's current assets represent 17.9% of total assets in 2025, an increase from 0.0% in 2022.
- Cash Position: Cash and equivalents constituted 11.6% of total assets in 2025, up from 0.0% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 80.0% of total assets, an increase from 0.0% in 2022.
- Asset Diversification: The largest asset category is intangible assets at 80.8% of total assets.
NANECH Competitors by Total Assets
Key competitors of NANECH based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
NANECH - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - NANECH generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - NANECH is currently not profitable relative to its asset base.
NANECH - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.89 | 1.24 | 5.00 |
| Quick Ratio | 0.89 | 1.24 | 5.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-392.00K | Skr 3.61 Million | Skr 10.39 Million |
NANECH - Advanced Valuation Insights
This section examines the relationship between NANECH's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.92 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -44.6% |
| Total Assets | Skr18.42 Million |
| Market Capitalization | $535.70K USD |
Valuation Analysis
Below Book Valuation: The market values NANECH's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NANECH's assets decreased by 44.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NANECH (2022–2025)
The table below shows the annual total assets of NANECH from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr18.42 Million | -44.62% |
| 2024-12-31 | Skr33.26 Million | +52.66% |
| 2023-12-31 | Skr21.78 Million | +51.41% |
| 2022-12-31 | Skr14.39 Million | -- |